Human cerebrospinal fluid fatty acid levels differ between supernatant fluid and brain-derived nanoparticle fractions, and are altered in Alzheimer's disease.

por Alfred N Fonteh, Matthew Cipolla, Jiarong Chiang, Xianghong Arakaki, Michael G Harrington
Publicado 2014

Retinal ganglion cell dysfunction in preclinical Alzheimer’s disease: an electrophysiologic biomarker signature

por Samuel Asanad, Christian M. Felix, Michele Fantini, Michael G. Harrington, Alfredo A. Sadun, Rustum Karanjia
Publicado 2021

Regional brain volumes relate to Alzheimer's disease cerebrospinal fluid biomarkers and neuropsychometry: A cross-sectional, observational study.

por Mark R Libowitz, Ke Wei, Thao Tran, Karen Chu, Kristina Moncrieffe, Michael G Harrington, Kevin King
Publicado 2021